Pricing Log in Create free account

Acumen Pharmaceuticals, Inc. (ABOS) vs NewcelX Ltd. (NCEL)

Acumen Pharmaceuticals, Inc. and NewcelX Ltd. are both Biotechnology companies. Acumen Pharmaceuticals, Inc. and NewcelX Ltd. are of similar size ($15.6M and $15.5M). Across the 9 metrics below, NewcelX Ltd. leads on 6 and Acumen Pharmaceuticals, Inc. on 3.

Valuation

Metric ABOS NCEL Biotechnology median
P/E n/m n/m 10.60
P/S 11.08 n/m 9.40
P/B 0.46 5.02 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.35 n/m 0.66
EV/Sales (25.36) n/m 9.02
Earnings yield (700.36%) (56.25%) (32.88%)
Free cash flow yield (553.34%) (16.18%) (23.13%)

Profitability

Metric ABOS NCEL Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (162.72%) 0.00% (51.96%)
Return on assets (91.28%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ABOS NCEL Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (16.96%) 11.18% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABOS NCEL Biotechnology median
Debt to equity 0.76 0.06 0.00
Current ratio 1.89 0.40 4.97
Net debt to EBITDA 0.69 0.74 1.01

Dividend

Metric ABOS NCEL Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ABOS NCEL Biotechnology median
Market cap 15.46m 15.56m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack